Why is Amdocs stock plummeting today?

Amdocs stock plunged 44.5% in after-hours trading after the company delivered a fiscal 2027 outlook that shocked investors, revealing that a legal dispute with T-Mobile had escalated into a formal conflict with both parties asserting material breaches and threatening termination or arbitration. While fiscal Q4 2026 results were in line with expectations — non-GAAP EPS of $1.98 and revenue of $1.194 billion — the forward guidance was a stark reversal: first-quarter FY2027 revenue was guided to a midpoint of $975 million, roughly 19% below the $1.2 billion consensus, and full-year adjusted EPS is projected to fall 26%–30% year-over-year. CEO Shimie Hortig acknowledged the situation as "an isolated situation with a large customer, resulting in a significant decline in our revenue and profitability outlook for next year."

Adding to the pressure, Oppenheimer moved swiftly on November 4 to downgrade Amdocs from Outperform to Perform, citing the anemic FY2027 outlook and the unresolved nature of the T-Mobile dispute. At least three analysts revised their earnings estimates downward, reinforcing the cautious tone. The company also announced it is exiting non-strategic businesses — including the divestiture of its media unit and hardware resale activities — which, while strategically logical, added near-term revenue uncertainty on top of the T-Mobile headwind.

The broader market context offered little cover for the selloff. The S&P 500 gained 0.2%, the Dow Jones rose 0.4%, and the NASDAQ edged up 0.2% during the regular session as markets absorbed U.S. midterm election results pointing to a Democratic sweep of Congress. The muted macro backdrop made Amdocs’s after-hours collapse all the more stark, as the decline was entirely driven by company-specific developments rather than any sector-wide or macroeconomic dislocation.

Taken together, the combination of a massive guidance miss, an unresolved and legally escalating dispute with one of its largest customers, an analyst downgrade, and a wave of estimate cuts created a perfect storm that sent Amdocs stock to $34.64 in after-hours trading — well below its 52-week low of $49.74 — as investors rapidly repriced the stock to reflect a fundamentally altered near-term earnings trajectory.